Literature DB >> 14989469

Metachromatic leukodystrophy: consequences of sulphatide accumulation.

V Gieselmann1, S Franken, D Klein, J E Mansson, R Sandhoff, R Lüllmann Rauch, D Hartmann, V P M Saravanan, P P De Deyn, R D'Hooge, A M Van Der Linden, N Schaeren-Wiemers.   

Abstract

UNLABELLED: Metachromatic leukodystrophy is a lysosomal lipid storage disorder. It is caused by mutations in the gene for arylsulphatase A, an enzyme involved in the degradation of the sphingolipid 3'-O-sulphogalactosylceramide (sulphatide). This membrane lipid can be found in various cell types, but in particularly high concentrations in the myelin of the nervous system. Patients suffer from progressive, finally lethal, demyelination due to accumulation of sulphatide. In the nervous system, lipid storage not only affects oligodendrocytes but also neurons and, in addition, leads to astrogliosis and activation of microglia. At the cellular level, lysosomal sulphatide storage also affects the lipid composition of myelin itself and has consequences for the amount and localization of particular myelin membrane-associated proteins. Here we review data, largely based on an arylsulphatase A knock-out mouse model of metachromatic leukodystrophy.
CONCLUSION: The knock-out mouse model of metachromatic leukodystrophy has provided insights into the histopathological and cellular consequences of sulphatide storage.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14989469     DOI: 10.1111/j.1651-2227.2003.tb00225.x

Source DB:  PubMed          Journal:  Acta Paediatr Suppl        ISSN: 0803-5326


  10 in total

Review 1.  Pathophysiology of neuropathic lysosomal storage disorders.

Authors:  Cinzia Maria Bellettato; Maurizio Scarpa
Journal:  J Inherit Metab Dis       Date:  2010-04-29       Impact factor: 4.982

2.  Comparative efficacy and safety of multiple routes of direct CNS administration of adeno-associated virus gene transfer vector serotype rh.10 expressing the human arylsulfatase A cDNA to nonhuman primates.

Authors:  Jonathan B Rosenberg; Dolan Sondhi; David G Rubin; Sébastien Monette; Alvin Chen; Sara Cram; Bishnu P De; Stephen M Kaminsky; Caroline Sevin; Patrick Aubourg; Ronald G Crystal
Journal:  Hum Gene Ther Clin Dev       Date:  2014-08-21       Impact factor: 5.032

Review 3.  Optic atrophies in metabolic disorders.

Authors:  Marjan Huizing; Brian P Brooks; Yair Anikster
Journal:  Mol Genet Metab       Date:  2005-09-27       Impact factor: 4.797

4.  Metachromatic leukodystrophy: natural course of cerebral MRI changes in relation to clinical course.

Authors:  Samuel Groeschel; Christiane Kehrer; Corinna Engel; Christine I Dali; Annette Bley; Robert Steinfeld; Wolfgang Grodd; Ingeborg Krägeloh-Mann
Journal:  J Inherit Metab Dis       Date:  2011-06-23       Impact factor: 4.982

5.  Dysfunction of platelet-derived growth factor receptor α (PDGFRα) represses the production of oligodendrocytes from arylsulfatase A-deficient multipotential neural precursor cells.

Authors:  Katarzyna C Pituch; Ana L Moyano; Aurora Lopez-Rosas; Felecia M Marottoli; Guannan Li; Chenqi Hu; Richard van Breemen; Jan E Månsson; Maria I Givogri
Journal:  J Biol Chem       Date:  2015-01-20       Impact factor: 5.157

Review 6.  Enzyme, cell and gene-based therapies for metachromatic leukodystrophy.

Authors:  C Sevin; P Aubourg; N Cartier
Journal:  J Inherit Metab Dis       Date:  2007-03-08       Impact factor: 4.750

7.  Early neurodegeneration progresses independently of microglial activation by heparan sulfate in the brain of mucopolysaccharidosis IIIB mice.

Authors:  Jérôme Ausseil; Nathalie Desmaris; Stéphanie Bigou; Ruben Attali; Sébastien Corbineau; Sandrine Vitry; Mathieu Parent; David Cheillan; Maria Fuller; Irène Maire; Marie-Thérèse Vanier; Jean-Michel Heard
Journal:  PLoS One       Date:  2008-05-28       Impact factor: 3.240

8.  Radioiodination of aryl-alkyl cyclic sulfates.

Authors:  Chandra Mushti; Mikhail I Papisov I Papisov
Journal:  Molecules       Date:  2012-11-07       Impact factor: 4.411

9.  Four novel ARSA gene mutations with pathogenic impacts on metachromatic leukodystrophy: a bioinformatics approach to predict pathogenic mutations.

Authors:  Masoumeh Dehghan Manshadi; Behnam Kamalidehghan; Omid Aryani; Elham Khalili; Sepideh Dadgar; Mahdi Tondar; Fatemeh Ahmadipour; Goh Yong Meng; Massoud Houshmand
Journal:  Ther Clin Risk Manag       Date:  2017-06-16       Impact factor: 2.423

Review 10.  Approach to Patients with Neurometabolic Diseases Who Show Characteristic Signs and Symptoms.

Authors:  Parvaneh Karimzadeh; Mohammad Ghofrani; Shahram Nasiri
Journal:  Iran J Child Neurol       Date:  2020
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.